“Healthcare providers call amyloidosis a “protein misfolding disorder.  Healthcare providers typically diagnose amyloidosis in people ages 50 to 65. The diseases affect more men and people assigned male at birth than women and people assigned female at birth. Healthcare providers may do several different tests, but ultimately, they use bone marrow aspiration and bone marrow biopsy to identify the mutated protein causing specific amyloidosis types.  MD’s do other tests also. Healthcare providers treat amyloidosis by treating symptoms and organ damage and by treating the underlying cause.”.

Cleveland Clinic (https://my.clevelandclinic.org/health/diseases/23398-amyloidosis)